Currently Viewing:
Currently Reading
What We're Reading: GOP Begins ACA Repeal Process With Budget Blueprint
January 12, 2017 – AJMC Staff
What We're Reading: Drug Development No Faster Than 20 Years Ago
January 11, 2017 – AJMC Staff
What We're Reading: HHS Will Take Swift Action on NC Medicaid Expansion Plan
January 10, 2017 – AJMC Staff
A Better Way to Cover High-Value Services
January 09, 2017 – Laura Joszt
AIDS Advocates Fear Potential Consequences of ACA Repeal
January 09, 2017 – Christina Mattina
What We're Reading: Meals on Wheels Becomes the "Eyes and Ears" of Healthcare Systems
January 09, 2017 – AJMC Staff
Medicare Catastrophic Coverage Spending Tripled Since 2010, OIG Reports
January 07, 2017 – Christina Mattina
This Week in Managed Care: January 6, 2017
January 06, 2017
What We're Reading: Democrats Suggest Bipartisan Effort to Overhaul ACA, Instead of Repeal
January 06, 2017 – AJMC Staff

What We're Reading: GOP Begins ACA Repeal Process With Budget Blueprint

AJMC Staff
What we're reading, January 12, 2017: Republicans begin process of repealing Obamacare by passing budget resolution; AbbVie's CEO promises to keep drug price increases to once a year and less than 10%; Cardinal Health will pay $44 million for not reporting suspicious opioid orders.
Republicans began the process of repealing the Affordable Care Act with a budget resolution that was passed 51-48. According to CNN, the Senate voted along party lines with 1 member absent and Senator Rand Paul (R-Kentucky) voting against the budget resolution. Paul has been vocal that a repeal of Obamacare should not be passed until a replacement has been created. The vote on the bill lasted well into the night, finishing up just before 1:30 am on Thursday. The House is expected to vote as early as Friday on the resolution.

Another drug maker has publicly promised to curb drug price increases. AbbVie’s CEO said at the annual JP Morgan Healthcare Conference that the company would raise prices once this year and all drug prices would stay under 10%, reported Reuters. The announcement follows similar ones from Allergan and Novo Nordisk and came on the same day that President-elect Donald J. Trump said in a news conference that pharmaceutical companies were “getting away with murder” for what they charged for medicines, causing stocks for drug companies to fall sharply.

As part of an agreement with the Department of Justice, Cardinal Health will pay $44 million in fines for not alerting the Drug Enforcement Administration (DEA) of suspicious orders of opioids. Distributors must alert the DEA of suspicious orders, but as part of a settlement in 2012, Cardinal acknowledged that it did not do so in Florida, Maryland, and New York, reported The Washington Post. This is not the first time Cardinal has reached such a settlement and paid large fines—in 2008, the company paid $34 million to settle similar allegations.

Copyright AJMC 2006-2020 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
Welcome the the new and improved, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up